peptide administration and usage
Melanotan 1 Injections: Complete Guide for 2026
May
Melanotan 1 Injections: The Complete Guide (2026)
Melanotan 1 injections are among the most searched melanocortin peptide topics — and yet the information available on this compound remains surprisingly scattered, frequently confused with Melanotan 2, and rarely presented with the combination of scientific accuracy and practical clarity that someone considering Melanotan 1 injections actually needs.
This guide changes that. Whether you are researching Melanotan 1 injections for the first time or looking to verify your existing understanding against accurate, up-to-date information — this is the most comprehensive and clearly structured Melanotan 1 injections guide available in 2026. It covers what Melanotan 1 is, how Melanotan 1 injections work at the biological level, the critical differences between Melanotan 1 and Melanotan 2 injections, dosage protocols, side effects, legal status, and where to find genuine Melanotan 1 at verified purity standards.
What Is Melanotan 1?
Melanotan 1 — also known by its pharmaceutical name afamelanotide — is a synthetic analogue of alpha-melanocyte stimulating hormone (α-MSH), a naturally occurring neuropeptide produced by the pituitary gland that plays a central role in regulating skin pigmentation, energy metabolism, inflammation, and several other physiological processes.
Melanotan 1 was developed in the 1980s at the University of Arizona as part of a programme investigating synthetic melanocortin peptides for their potential to stimulate skin tanning without UV radiation exposure. The research team — led by Dr Victor Hruby and Dr Mac Hadley — synthesised multiple analogues of native α-MSH, of which Melanotan 1 was among the first to demonstrate stable biological activity in the melanocortin receptor system.
What makes Melanotan 1 particularly significant is that it subsequently progressed through formal pharmaceutical development and received regulatory approval in Europe and Australia as a licensed pharmaceutical product — branded as Scenesse (afamelanotide 16mg implant) — for the treatment of erythropoietic protoporphyria (EPP), a rare genetic disorder causing severe phototoxic skin reactions to sunlight. This regulatory approval gives Melanotan 1 injections a clinical legitimacy that its better-known sibling Melanotan 2 does not possess — Melanotan 1 is the only melanocortin tanning peptide with an approved pharmaceutical form.
How Melanotan 1 Injections Work
Melanotan 1 injections produce their effects by binding to and activating melanocortin receptors — specifically the MC1 receptor (MC1R) expressed on melanocytes, the specialised skin cells responsible for producing melanin.
When Melanotan 1 binds to MC1R following injection, it triggers the melanocyte to produce and release melanin — the pigment that gives skin, hair, and eyes their colour and that provides the skin’s primary defence against UV radiation damage. This melanogenesis stimulation from Melanotan 1 injections produces a gradual darkening of the skin — a tanning effect — that occurs independently of UV exposure, though the effect is significantly enhanced when combined with moderate UV exposure.
The MC1 receptor selectivity of Melanotan 1 injections is one of its defining pharmacological characteristics. Unlike Melanotan 2, which activates multiple melanocortin receptor subtypes simultaneously — including MC3R, MC4R, and MC5R alongside MC1R — Melanotan 1 injections are relatively selective for MC1R. This receptor selectivity profile directly determines the side effect difference between Melanotan 1 and Melanotan 2 injections, which is one of the most important distinctions covered in this guide.
As documented in PubMed’s afamelanotide clinical research index, the MC1R activation mechanism of Melanotan 1 has been extensively validated in both preclinical and clinical settings — providing a well-characterised pharmacological foundation for understanding Melanotan 1 injection effects.
Melanotan 1 vs Melanotan 2 Injections: The Critical Differences
This is the comparison that most searchers researching Melanotan 1 injections are ultimately trying to understand — and getting it right is essential to making an informed decision about which compound to use.
| Factor | Melanotan 1 Injections | Melanotan 2 Injections |
|---|---|---|
| Chemical structure | Linear α-MSH analogue | Cyclic α-MSH analogue |
| Receptor selectivity | Primarily MC1R | MC1R + MC3R + MC4R + MC5R |
| Primary effect | Skin tanning through melanogenesis | Tanning + sexual arousal + appetite suppression |
| Tanning effect | Strong, gradual, natural-looking | Strong, faster onset |
| Sexual arousal effect | Minimal — MC4R activation very low | Significant — MC4R drives libido increase |
| Appetite suppression | Minimal | Notable — MC4R and MC3R involvement |
| Nausea incidence | Lower — more selective receptor profile | Higher — broader receptor activation |
| Facial flushing | Lower incidence | More common |
| Pharmaceutical status | FDA/EMA approved as Scenesse for EPP | Not approved — research compound only |
| Half-life | Approximately 1–2 hours (injection form) | Approximately 1–2 hours |
| Best for | Tanning focus, lower side effect profile, EPP | Tanning + libido + appetite suppression combined |
The most practically significant difference between Melanotan 1 and Melanotan 2 injections is the side effect profile driven by receptor selectivity. Because Melanotan 2 activates MC4R — the receptor responsible for sexual arousal and appetite regulation — Melanotan 2 injections reliably produce sexual arousal, spontaneous erections in men, and appetite suppression alongside tanning. These effects are absent or minimal with Melanotan 1 injections due to its MC1R selectivity.
For individuals whose primary goal is skin tanning — particularly those who are photosensitive, have fair skin that burns rather than tans, or have conditions like EPP — Melanotan 1 injections offer a cleaner, more targeted approach with a better-characterised safety profile. For individuals who want the combined tanning, libido, and appetite effects, Melanotan 2 is the more relevant compound. Our Melanotan 2 product page covers Melanotan 2 in full detail for those seeking the broader melanocortin receptor activation profile.
Melanotan 1 Injections: Benefits and Research Applications
Based on the published clinical and preclinical research on Melanotan 1 injections, the following effects have been documented:
Skin tanning without UV requirement — Melanotan 1 injections stimulate melanogenesis independently of UV exposure through direct MC1R activation. The tanning effect from Melanotan 1 injections is gradual, natural-looking, and proportional to the individual’s baseline skin type and melanocyte density. Individuals with fair skin (Fitzpatrick types I and II) typically respond more slowly to Melanotan 1 injections than those with medium skin tones (types III and IV), though all skin types capable of producing melanin respond to some degree.
UV photoprotection — The increased melanin density produced by Melanotan 1 injections provides genuine photoprotective benefit — elevated melanin absorbs UV radiation more efficiently, reducing the proportion that reaches DNA in skin cells. This is the mechanism underlying Melanotan 1’s pharmaceutical application in EPP — in EPP patients, the increased melanin from Melanotan 1 injections significantly reduces the phototoxic reactions triggered by sunlight exposure.
Anti-inflammatory activity — Melanotan 1 injections demonstrate anti-inflammatory activity through MC1R signalling in immune cells. Research has investigated Melanotan 1’s potential anti-inflammatory applications beyond its tanning properties — including in inflammatory skin conditions, ischaemia-reperfusion injury, and metabolic inflammation models. As reviewed in Rupa Health’s melanocortin peptide overview, the anti-inflammatory dimension of Melanotan 1 injections is one of several therapeutic areas where melanocortin research extends well beyond cosmetic tanning applications.
Potential neuroprotective properties — Emerging research has investigated MC1R signalling in the central nervous system — with evidence suggesting melanocortin peptide activity may have neuroprotective implications. This research remains early-stage but adds to the mechanistic breadth of interest in Melanotan 1 injections beyond skin pigmentation.
These statements reflect current research findings. Melanotan 1 outside of the pharmaceutical Scenesse implant is supplied as a research compound. Always consult a qualified healthcare professional before beginning any Melanotan 1 protocol.
Melanotan 1 Injections: Dosage Guide
The following Melanotan 1 injection dosage information is provided for reference based on published research protocols. It does not constitute medical advice.
Research-grade Melanotan 1 injection dosage:
- Dose: 0.5 mg to 1 mg per injection
- Frequency: Daily during loading phase, reducing to every 2 to 3 days for maintenance once desired tan is achieved
- Administration: Subcutaneous injection — abdomen, outer thigh, or upper arm
- Loading phase: 10 to 20 daily Melanotan 1 injections to build initial melanin density
- Maintenance phase: 2 to 3 Melanotan 1 injections per week to maintain pigmentation
Melanotan 1 injection timing and UV exposure: While Melanotan 1 injections stimulate melanogenesis independently of UV, moderate UV exposure during the loading phase significantly accelerates the visible tanning result. This is because UV exposure activates existing melanocytes alongside the MC1R stimulation from Melanotan 1 injections — the two signals work synergistically. Brief, non-burning UV exposure of 10 to 20 minutes during the Melanotan 1 injection loading phase produces faster and more even tanning results than Melanotan 1 injections alone.
Melanotan 1 injection reconstitution: Research-grade Melanotan 1 is supplied as a lyophilized powder requiring reconstitution with bacteriostatic water before injection. The standard reconstitution ratio for Melanotan 1 injections is 1ml to 2ml of bacteriostatic water per 10mg vial. Use our peptide reconstitution calculator to calculate your exact draw volume for any Melanotan 1 injection dose.
Melanotan 1 Injections: Side Effects
Understanding the side effect profile of Melanotan 1 injections is essential before beginning any protocol. The side effects of Melanotan 1 injections are generally considered milder than those of Melanotan 2 due to the more selective MC1R receptor profile:
Nausea — The most commonly reported side effect of Melanotan 1 injections, particularly during the initial loading phase when the body is first adapting to MC1R activation. Nausea from Melanotan 1 injections is typically mild and transient — most users find it resolves within 30 to 60 minutes of injection and diminishes significantly after the first 3 to 5 Melanotan 1 injections as tolerance develops. Administering Melanotan 1 injections before sleep reduces the perceived impact of nausea for most users.
Facial flushing — Temporary facial redness following Melanotan 1 injections — more common during the loading phase and typically subsiding as the body adapts to the melanocortin receptor stimulation.
Fatigue — Some users of Melanotan 1 injections report mild fatigue or drowsiness in the 1 to 2 hours following injection, which is why evening administration is often preferred.
Mole and freckle darkening — Melanotan 1 injections stimulate melanin production in all melanocytes — including those in existing moles and freckles, which may darken temporarily during a Melanotan 1 injection protocol. Any existing pigmented lesions should be assessed by a dermatologist before beginning Melanotan 1 injections, and any mole that changes shape, border, or colour irregularly during a protocol should be evaluated promptly.
Minimal sexual side effects — Unlike Melanotan 2 injections, Melanotan 1 injections do not produce significant sexual arousal, spontaneous erections, or libido changes due to the relative absence of MC4R activation. This is consistently cited as a primary advantage of Melanotan 1 injections over Melanotan 2 for users whose sole objective is skin tanning.
Melanotan 1 Injections: Legal Status in 2026
The legal status of Melanotan 1 injections requires careful consideration before purchase.
Pharmaceutical Melanotan 1 (Scenesse/afamelanotide) — FDA-approved for EPP treatment in the United States and EMA-approved in Europe. Available only by prescription from qualified healthcare providers for the approved indication. Not available over the counter.
Research-grade Melanotan 1 — Legal to purchase for in vitro laboratory research purposes in most countries. TitanForge Peptides supplies research-grade Melanotan 1 in compliance with all applicable regulations. Research-grade Melanotan 1 injections are for laboratory research use only and are not for human therapeutic self-administration.
WADA status — Melanotan 1 is listed on the WADA prohibited list as a prohibited substance in competitive sport under the peptide hormones and melanocortin receptor agonists category. Any competitive athlete subject to WADA testing must not use Melanotan 1 injections.
Always verify the laws applicable in your country before purchasing Melanotan 1 injections. Regulatory status varies by jurisdiction and changes over time.
Buying Genuine Melanotan 1 Injections: What to Verify
The Melanotan 1 injection market has a significant quality variation problem — with many suppliers offering products of unverified purity, incorrect labelling, or in some cases Melanotan 2 sold as Melanotan 1. Before purchasing Melanotan 1 injections from any supplier, verify the following:
Independent COA — A legitimate Melanotan 1 injection supplier provides a batch-specific Certificate of Analysis from an ISO-accredited independent laboratory confirming HPLC purity of minimum 98% to 99% and Mass Spectrometry identity verification of the correct Melanotan 1 compound. As reviewed in Examine.com’s melanocortin research overview, compound identity verification is particularly important in the Melanotan market where Melanotan 1 and Melanotan 2 are frequently confused or substituted.
GMP manufacturing — Research-grade Melanotan 1 injections should be manufactured in GMP-certified facilities to ensure consistent sterility and quality.
Correct compound identification — Confirm the product is specifically Melanotan 1 (afamelanotide) and not Melanotan 2. Molecular weight verification on the COA confirms this — Melanotan 1 has a molecular weight of 1,646.9 g/mol, while Melanotan 2 has a molecular weight of 1,024.2 g/mol. These are entirely different compounds.
TitanForge Peptides supplies research-grade Melanotan 1 at independently verified minimum 99% purity with full batch-specific COA documentation available on our Lab Results page. Shop Melanotan 1 here.
Frequently Asked Questions
Q: What is the difference between Melanotan 1 and Melanotan 2 injections? A: Melanotan 1 injections are primarily selective for the MC1R receptor — producing tanning with a lower incidence of sexual arousal, nausea, and appetite suppression than Melanotan 2. Melanotan 2 injections activate multiple melanocortin receptors including MC4R — producing tanning alongside significant sexual arousal and appetite suppression effects. Melanotan 1 has an approved pharmaceutical form (Scenesse) for EPP treatment. Melanotan 2 does not.
Q: How long do Melanotan 1 injection results last? A: The tanning effect from Melanotan 1 injections gradually fades over 4 to 8 weeks following cessation of the protocol as normal skin cell turnover replaces pigmented cells. Maintenance Melanotan 1 injections of 2 to 3 times weekly can sustain the tanning result indefinitely. UV avoidance accelerates fading while moderate UV exposure helps maintain pigmentation.
Q: How quickly do Melanotan 1 injections work? A: Initial colour change from Melanotan 1 injections is typically noticeable after 5 to 10 daily injections — approximately 1 to 2 weeks into the loading phase. The full tanning effect from Melanotan 1 injections develops over 3 to 6 weeks of consistent loading phase use. Results vary based on natural skin type and melanocyte density.
Q: Do Melanotan 1 injections cause sexual arousal? A: No — Melanotan 1 injections do not produce significant sexual arousal. This is a primary differentiator from Melanotan 2 injections, which strongly activate MC4R — the receptor responsible for the libido and arousal effects associated with Melanotan 2. Users specifically seeking the sexual arousal effects should consider Melanotan 2 or PT-141 instead. See our PT-141 product page and Melanotan 2 product page for alternatives.
Q: Are Melanotan 1 injections safe? A: Melanotan 1 has the most established clinical safety profile of any synthetic melanocortin peptide — having progressed through formal pharmaceutical development and received regulatory approval as Scenesse in Europe and the US for EPP. The most common side effects of Melanotan 1 injections are mild nausea and temporary flushing during the loading phase. Individuals with pre-existing melanocytic lesions or a personal or family history of melanoma should consult a dermatologist before considering Melanotan 1 injections.
Q: Where can I buy Melanotan 1 for research? A: TitanForge Peptides supplies research-grade Melanotan 1 at independently verified 99%+ purity with a full Certificate of Analysis. Shop Melanotan 1 here.
